Symbiotec Pharmalab Ltd

NSE: SYMBIOTEC · BSE: 544889 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹1,538.60
Market cap: ₹9,886 Cr
Revenue (annual): ₹869.1 Cr
Net profit (annual): ₹109.9 Cr
Promoter holding: 33.28%
FII holding: 3.79%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Earnings Call 4 Share Pledge 2 Results Update 2 Board Meeting Date 2 Financial Results 1 Capital Structure Change 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

29 Sep 2026 10:52 IST BSE

Business Update

Symbiotec Pharmalab Business Update

Symbiotec Pharmalab received an Establishment Inspection Report (EIR) from the U.S. FDA for its Pithampur manufacturing facility. The inspection concluded with a Voluntary Action Indicated (VAI) classification.

From: U.S. Food and Drug Administration (U.S. FDA)

Open announcement → Read the filing ↗